首页> 美国卫生研究院文献>Experimental and Therapeutic Medicine >Endoscopic balloon dilation and submucosal injection of triamcinolone acetonide in the treatment of esophageal stricture: A single-center retrospective study
【2h】

Endoscopic balloon dilation and submucosal injection of triamcinolone acetonide in the treatment of esophageal stricture: A single-center retrospective study

机译:内镜球囊扩张术和粘膜下注射曲安奈德治疗食管狭窄:单中心回顾性研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Effect and prognosis of endoscopic balloon dilatation combined with submucosal triamcinolone acetonide on treating benign esophageal lesions were explored. This retrospective study included patients with esophageal stricture treated in the Department of Gastroenterology, the Third Affiliated Hospital of Soochow University from March 2012 to March 2015. Enrolled patients were divided into the treatment and control group depending on the therapy differences. Endoscopic balloon dilation combined with submucosal injection of triamcinolone acetonide was performed in the treatment group and the endoscopic balloon dilatation was performed in the control group. In addition, the treatment group was further divided into the <16- and >16-mm subgroup according to the degree of balloon dilatation. During 1-year follow-up, changes of esophageal stenosis, esophageal stenosis recurrence rate, postoperative complications and adverse reactions were observed and analyzed. The improvement of esophageal stenosis of the treatment group was significantly superior to that of the control group at 2 and 4 months after operation, respectively (P=0.002, 0.013). The esophageal stenosis recurrence rate was 62.2 and 77.2% in the treatment and control group, respectively (P=0.027); the recurrence time of stenosis was 101.4±8.6 days in the treatment group and 75.4±5.2 days in the control group (P=0.006). Additionally, the recurrence time of esophageal stenosis was significantly shorter in the >16-mm subgroup compared with that of the <16-mm subgroup (P<0.001). Endoscopic balloon dilatation combined with local injection of triamcinolone acetonide in the treatment of esophageal stricture had a better therapeutic effect than that of the simple balloon dilatation, which was more effective when the balloon dilatation was >16 mm. It could significantly prolong the recurrence time of esophageal stricture.
机译:探讨了内镜下球囊扩张术联合粘膜下曲安奈德丙酮治疗食管良性病变的疗效和预后。这项回顾性研究包括2012年3月至2015年3月在苏州大学第三附属医院消化内科治疗的食管狭窄患者。根据治疗差异将入选患者分为治疗组和对照组。内镜下球囊扩张术联合黏膜下注射曲安奈德治疗组,内镜下球囊扩张术对照组。另外,根据球囊扩张程度,将治疗组进一步分为<16mm和> 16mm亚组。在1年的随访期间,观察并分析了食管狭窄的变化,食管狭窄的复发率,术后并发症和不良反应。术后2个月和4个月,治疗组食管狭窄的改善明显优于对照组(P = 0.002,0.013)。治疗组和对照组的食管狭窄复发率分别为62.2%和77.2%(P = 0.027)。狭窄的复发时间在治疗组为101.4±8.6天,在对照组为75.4±5.2天(P = 0.006)。此外,与<16mm亚组相比,> 16mm亚组的食管狭窄复发时间明显缩短(P <0.001)。内镜下球囊扩张联合局部注射曲安奈德治疗食管狭窄比单纯球囊扩张有更好的治疗效果,当球囊扩张> 16mm时更有效。可以明显延长食管狭窄的复发时间。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号